NeoGenomics, Inc.
NeoGenomics, Inc. (NEO) is a US-based specialised diagnostics company focused on cancer testing and pathology services. It operates a network of clinical laboratories that offer genetic sequencing, blood-based assays and advanced tumour profiling to oncologists, hospitals and biopharma clients. Revenue growth has been driven by rising demand for precision oncology tests, expanding test menus and strategic acquisitions that broaden geographic reach and capabilities. Investors should note the company’s exposure to reimbursement rates, lab utilisation and regulatory oversight — which can affect margins and volume. With a market capitalisation around $1.35 billion, NeoGenomics sits in the small‑cap / mid‑cap range and can show higher volatility than large diversified peers. The business can benefit from secular growth in personalised medicine, but outcomes depend on execution, pricing pressure and test adoption. This summary is for general educational purposes and not personalised investment advice; returns are not guaranteed and values can fall as well as rise.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying NeoGenomics' stock with a target price of $12.33, indicating potential growth.
Financial Health
NeoGenomics is generating steady revenue and cash flow, but profits are low and margins are tight.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring NEO
The Alzheimer's Treatment Ecosystem
Following the EU regulator's approval of Eli Lilly's Alzheimer's drug, Kisunla, a new investment opportunity has emerged. This theme focuses on companies that provide essential support services, such as genetic testing and advanced imaging, which are crucial for the drug's administration and monitoring.
Published: July 27, 2025
Explore BasketDiagnostic Takeover Targets
This carefully selected group of stocks features innovative diagnostic companies that could become acquisition targets following recent takeover interest in the sector. Professional analysts have identified these companies for their unique technologies and established market positions in a consolidating healthcare landscape.
Published: July 15, 2025
Explore BasketLiquid-Biopsy Diagnostics
These innovative companies are developing revolutionary blood tests that can detect cancer earlier and more accurately than ever before. Carefully selected by healthcare investment experts, this collection represents the forefront of non-invasive diagnostics poised to transform the multi-billion dollar oncology market.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Tumour Profiling Growth
Rising demand for personalised oncology tests supports revenue expansion, though adoption rates and pricing can vary by region and payer.
Lab Network Expansion
Acquisitions and capacity investments can drive scale and service breadth, but integration and execution risks may affect near‑term margins.
Reimbursement Sensitivity
Revenue is sensitive to reimbursement policies and insurer decisions; favourable coverage boosts volumes, while cuts can pressure earnings.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Chemed Corp.
Provides hospice and palliative care services to patients facing life-limiting illness
Alignment Healthcare, Inc.
Alignment Healthcare, Inc. is a consumer-centric platform designed to improve the healthcare experience for seniors. The Company’s operations primarily consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. It partners with local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology (AVA). AVA’s capabilities include consumer experience, internal care delivery, external providers, health plan operations and growth operations. AVA offers a digital ecosystem that enables its members and their support system to get the information and care they need, when and how they need it. With their AVA-powered member portal and mobile app, seniors have many self-service capabilities and can get 24/7 care, send secure messages to their concierge and care teams, check their rewards and ACCESS On-Demand Concierge Card balance, and view their health history.
Brookdale Senior Living Inc.
A leading owner and operator of senior living communities in the United States.
